The Netherlands Mental Health Survey and Incidence Study-3 (NEMESIS-3): Objectives, Methods and Baseline Characteristics of the Sample

Overview

Journal Int J Methods Psychiatr Res

Specialty Psychiatry

Date 2022 Sep 2

PMID 36054177

Authors

Margreet Ten Have

Marlous Tuithof

Saskia van Dorsselaer

Frederiek Schouten

Ron de Graaf

Affiliations

Soon will be listed here.

Abstract

Objectives: NEMESIS-3 (Netherlands Mental Health Survey and Incidence Study-3) is a psychiatric epidemiological cohort study of the Dutch general population that replicates and expands on two previous NEMESIS-studies conducted in 1996-1999 and 2007-2018 respectively. The main aims of NEMESIS-3 are to provide up-to-date information on the prevalence, incidence, course and consequences of mental disorders, their risk indicators, and to study the relevant time trends. This paper gives an overview of the objectives and methods of NEMESIS-3, especially of the recently completed first wave, and describes the sample characteristics.

Methods: NEMESIS-3 is based on a multistage, stratified random sampling of individuals aged 18-75 years. Face-to-face interviews were laptop computer-assisted and held at the respondent's home. A slightly modified Composite International Diagnostic Interview (CIDI) version 3.0 was used to assess both Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) and DSM-5 mental disorders. Two follow-up waves are planned three and six years after baseline.

Results: In the first wave, performed from November 2019 to March 2022, 6194 individuals were interviewed: 1576 respondents before and 4618 respondents during the COVID-19 pandemic. The average interview duration was 91 min and the response rate was 54.6%. The sample consisted of 50.4% women and had a mean age of 47.9 years. The sample was reasonable nationally representative, although some sociodemographic groups were somewhat underrepresented.

Conclusions: Despite the COVID-19 restrictions, we were able to build a large and comprehensive dataset of good quality, permitting us to investigate the latest trends in mental health status, various new topics related to mental health, and the extent to which the pandemic has had an effect on the population's mental health.

Citing Articles

Prodromal symptoms of a first manic episode: a qualitative study to the perspectives of patients with bipolar disorder and their caregivers'.

Maassen E, Maathuis L, Regeer B, Kupka R, Regeer E Int J Bipolar Disord. 2024; 12(1):38.

PMID: 39542978 PMC: 11564498. DOI: 10.1186/s40345-024-00360-9.

Validity of the five-item mental health inventory for screening current mood and anxiety disorders in the general population.

Have M, Van Bon-Martens M, Schouten F, van Dorsselaer S, Shields-Zeeman L, Luik A Int J Methods Psychiatr Res. 2024; 33(3):e2030.

PMID: 38956889 PMC: 11219508. DOI: 10.1002/mpr.2030.

Lifetime prevalence, risk, and treatment of mood and anxiety disorders in Qatar's national mental health study.

Khaled S, Alhussaini N, Alabdulla M, Sampson N, Kessler R, Woodruff P Int J Methods Psychiatr Res. 2024; 33(S1):e2011.

PMID: 38726890 PMC: 11323770. DOI: 10.1002/mpr.2011.

"It has to be better, otherwise we will get stuck." A Review of Novel Directions for Mental Health Reform and Introducing Pilot Work in the Netherlands.

van Os J, Scheepers F, Milo M, Ockeloen G, Guloksuz S, Delespaul P Clin Pract Epidemiol Ment Health. 2024; 19:e17450179271206.

PMID: 38680529 PMC: 11046893. DOI: 10.2174/0117450179271206231114064736.

Protocol of a prospective community-based study about the onset and course of depression in a nationally representative cohort of adults in China: the China Depression Cohort Study-I.

Li X, Tian Y, Phillips M, Xiao S, Zhang X, Li Z BMC Public Health. 2023; 23(1):1617.

PMID: 37620799 PMC: 10463817. DOI: 10.1186/s12889-023-16542-6.

References

Kessler R, Angermeyer M, Anthony J, de Graaf R, Demyttenaere K, Gasquet I . Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry. 2008; 6(3):168-76. PMC: 2174588. View

Bijl R, Ravelli A, Van Zessen G . Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 1998; 33(12):587-95. DOI: 10.1007/s001270050098. View

Grant B, Goldstein R, Chou S, Huang B, Stinson F, Dawson D . Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2008; 14(11):1051-66. PMC: 2766434. DOI: 10.1038/mp.2008.41. View

Scholten W, Have M, van Geel C, van Balkom A, de Graaf R, Batelaan N . Recurrence of anxiety disorders and its predictors in the general population. Psychol Med. 2021; 53(4):1334-1342. PMC: 10009370. DOI: 10.1017/S0033291721002877. View

Tuithof M, Have M, van den Brink W, Vollebergh W, de Graaf R . Predicting persistency of DSM-5 alcohol use disorder and examining drinking patterns of recently remitted individuals: a prospective general population study. Addiction. 2013; 108(12):2091-9. DOI: 10.1111/add.12309. View

Bockting W, Benner A, Coleman E . Gay and bisexual identity development among female-to-male transsexuals in North America: emergence of a transgender sexuality. Arch Sex Behav. 2009; 38(5):688-701. DOI: 10.1007/s10508-009-9489-3. View

Ormel J, Oldehinkel A, Nolen W, Vollebergh W . Psychosocial disability before, during, and after a major depressive episode: a 3-wave population-based study of state, scar, and trait effects. Arch Gen Psychiatry. 2004; 61(4):387-92. DOI: 10.1001/archpsyc.61.4.387. View

Have M, Tuithof M, van Dorsselaer S, Schouten F, de Graaf R . The Netherlands Mental Health Survey and Incidence Study-3 (NEMESIS-3): Objectives, methods and baseline characteristics of the sample. Int J Methods Psychiatr Res. 2022; 32(1):e1942. PMC: 9976606. DOI: 10.1002/mpr.1942. View

Buist-Bouwman M, Ormel J, de Graaf R, Vollebergh W . Functioning after a major depressive episode: complete or incomplete recovery?. J Affect Disord. 2004; 82(3):363-71. DOI: 10.1016/j.jad.2004.02.007. View

10.

Kessler R, Ruhm C, Puac-Polanco V, Hwang I, Lee S, Petukhova M . Estimated Prevalence of and Factors Associated With Clinically Significant Anxiety and Depression Among US Adults During the First Year of the COVID-19 Pandemic. JAMA Netw Open. 2022; 5(6):e2217223. PMC: 9201669. DOI: 10.1001/jamanetworkopen.2022.17223. View

11.

Andrews G, Peters L . The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol. 1998; 33(2):80-8. DOI: 10.1007/s001270050026. View

12.

Tuithof M, Have M, van Dorsselaer S, Kleinjan M, Beekman A, de Graaf R . Course of subthreshold depression into a depressive disorder and its risk factors. J Affect Disord. 2018; 241:206-215. DOI: 10.1016/j.jad.2018.08.010. View

13.

Wittchen H . Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res. 1994; 28(1):57-84. DOI: 10.1016/0022-3956(94)90036-1. View

14.

de Graaf R, Have M, Tuithof M, van Dorsselaer S . First-incidence of DSM-IV mood, anxiety and substance use disorders and its determinants: results from the Netherlands Mental Health Survey and Incidence Study-2. J Affect Disord. 2013; 149(1-3):100-7. DOI: 10.1016/j.jad.2013.01.009. View

15.

Von Korff M, Crane P, Alonso J, Vilagut G, Angermeyer M, Bruffaerts R . Modified WHODAS-II provides valid measure of global disability but filter items increased skewness. J Clin Epidemiol. 2008; 61(11):1132-43. PMC: 3277915. DOI: 10.1016/j.jclinepi.2007.12.009. View

16.

Levine D, Kripke D, Kaplan R, Lewis M, Naughton M, Bowen D . Reliability and validity of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess. 2003; 15(2):137-48. DOI: 10.1037/1040-3590.15.2.137. View

17.

Haro J, Arbabzadeh-Bouchez S, Brugha T, de Girolamo G, Guyer M, Jin R . Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Int J Methods Psychiatr Res. 2007; 15(4):167-80. PMC: 6878271. DOI: 10.1002/mpr.196. View

18.

Bijl R, Ravelli A . Current and residual functional disability associated with psychopathology: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med. 2000; 30(3):657-68. DOI: 10.1017/s0033291799001841. View

19.

Bijl R, Ravelli A . Psychiatric morbidity, service use, and need for care in the general population: results of The Netherlands Mental Health Survey and Incidence Study. Am J Public Health. 2001; 90(4):602-7. PMC: 1446190. DOI: 10.2105/ajph.90.4.602. View

20.

. Evaluation of National Health Interview Survey diagnostic reporting. Vital Health Stat 2. 1994; (120):1-116. View